Tipping the Scale for Better Global Health

Blue and green planet with green heartbeat line on either side

“We need to understand how individuals in low and middle-income countries make decisions about their health while facing multiple constraints and worries in their lives, and which behavioural factors might tilt optimal decisions.” This states professor Matthias Rieger in his inaugural lecture entitled What Tips the Scale? Global Health Behaviors and Randomized Trials. On Friday 20 November he will publicly accept his appointment as a professor in Global Health at Erasmus School of Health Policy & Management (ESHPM)

While a lot of health progress has been made in low- and middle-income countries, preventable illnesses and avoidable deaths persist. Child mortality in Sub-Saharan Africa, for example, declined quite rapidly since 1990. And countries like Ethiopia have seen improvements in maternal mortality by enhancing access to basic health services. But such gains have slowed down in recent years. Basic solutions to address risk factors are often available, yet a growing literature shows that they are not always consistently used or effectively deployed at scale.

In the coming years, Rieger will establish the Global Health Behaviors Lab at ESHPM. The lab will be a virtual, international network that collects long-standing research and societal partnerships across countries to study together how individuals, families, health workers and policymakers weigh the costs and benefits of health investments, and which behavioural factors might influence such decisions.

Using behavioural economic insights and randomised controlled trials (RCTs) and field experiments, the lab will test practical and potentially scalable interventions to support prevention, access to care, medication adherence and healthier choices. The lab will covers areas such as tuberculosis, nutrition, child health and unnecessary use of antibiotics. First joint studies are currently under way or in planning in Indonesia, Vietnam and South Africa. 

Tuberculosis in South Africa

A key area of research will be tuberculosis in South Africa. Although medication is often available at no cost, the tuberculosis treatment journey itself is long and burdensome. It can take six months and involves side effects, travel costs, stigma and loss of income or employment. And basic behavioural factors are at play too. For example, patients need to remember to take their medication daily. 

Rieger and his collaborators including professor Ronelle Burger at Stellenbosch University are investigating whether digital support, nutritional assistance and improved access to social benefits can help patients complete treatment successfully.

“While we are all hoping for medical advances for TB patients, it does not come down to medical fixes only,” says Rieger. “We need to understand the everyday constraints and contexts of tuberculosis patients, addressing poverty, food insecurity and incomplete social protection systems.”

The lab will also study the growing burden of overweight and obesity in low- and middle-income countries with partners at Sebelas Maret University, Wageningen University and the University of Economics Ho Chi Minh City, including how food environments, peer influence and young people’s autonomy shape dietary choices.

Rieger stresses that rigorous experiments are only a first step. Promising interventions must also be workable and scalable within complex health systems, and fit financing constraints.

“We don’t only want to show which interventions work in experiments,” he says. “We also want to work on how our research is fed back to study participants and policymakers, and how interventions could be successfully implemented at scale.”

About Professor Matthias Rieger

Matthias is a development economist, working and teaching in the interdisciplinary fields of global health and development studies. His research has focused on the economic and behavioural determinants of health and nutrition outcomes. He primarily relies on randomized control trials or field experiments, as well as quasi-experimental methods. Since joining ESHPM in January 2024, Rieger has been chairing the Global Health Theme at ESHPM. He also works part-time at the Institute of Social Studies (ISS) in The Hague.

Professor
Related content
Global Health and Development Economics Symposium, followed by Matthias Rieger’s lecture on global health behaviors and randomised trials.
Matthias Rieger
Related links
Research: Mobile Health Support for Tuberculosis

Compare 0 study programme